Xenon Pharma CEO Buys $1.12M in Shares, Stock Rallies
Xenon Pharmaceuticals CEO Ian Mortimer bought 30,000 shares for $1.12 million, part of a larger insider buying spree totaling $1.68 million. The company is advancing its lead epilepsy drug, Azetukalner.
Xenon Pharmaceuticals (XENE) was on investors’ radar on Thursday after the biotech company’s top executives bought a combined $1.68 million in shares, as the company advances its lead epilepsy drug, Azetukalner.On Thursday, CEO Ian Mortimer bought 30,000 shares at $37.38 apiece, worth about $1.12 m…